387 related articles for article (PubMed ID: 30636608)
21. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.
Escobar T; Yu CR; Muljo SA; Egwuagu CE
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4017-25. PubMed ID: 23674757
[TBL] [Abstract][Full Text] [Related]
22. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
[TBL] [Abstract][Full Text] [Related]
23. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
[TBL] [Abstract][Full Text] [Related]
24. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
25. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis.
Hara Y; Caspi RR; Wiggert B; Chan CC; Streilein JW
Curr Eye Res; 1992; 11 Suppl():97-100. PubMed ID: 1424755
[TBL] [Abstract][Full Text] [Related]
26. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established experimental autoimmune uveoretinitis.
Raveney BJ; Richards C; Aknin ML; Copland DA; Burton BR; Kerr E; Nicholson LB; Williams NA; Dick AD
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4008-17. PubMed ID: 18469197
[TBL] [Abstract][Full Text] [Related]
27. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.
Lee DJ; Biros DJ; Taylor AW
Int Immunopharmacol; 2009 Aug; 9(9):1079-86. PubMed ID: 19426838
[TBL] [Abstract][Full Text] [Related]
28. The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.RIII mice.
Chen J; Vistica B; Wiggert B; Chan CC; Gery I
Ocul Immunol Inflamm; 2005 Feb; 13(1):13-7. PubMed ID: 15804764
[TBL] [Abstract][Full Text] [Related]
29. Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis.
Silver PB; Horai R; Chen J; Jittayasothorn Y; Chan CC; Villasmil R; Kesen MR; Caspi RR
J Immunol; 2015 Apr; 194(7):3011-9. PubMed ID: 25716996
[TBL] [Abstract][Full Text] [Related]
30. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen.
Fox GM; Kuwabara T; Wiggert B; Redmond TM; Hess HH; Chader GJ; Gery I
Clin Immunol Immunopathol; 1987 May; 43(2):256-64. PubMed ID: 3494559
[TBL] [Abstract][Full Text] [Related]
31. IRBP-specific Th1 cells from peripheral blood were predominant in the experimental autoimmune uveitis.
Wu Y; Lin G; Sun B
Biochem Biophys Res Commun; 2003 Feb; 302(1):150-5. PubMed ID: 12593862
[TBL] [Abstract][Full Text] [Related]
32. KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis.
Niu T; Cheng L; Wang H; Zhu S; Yang X; Liu K; Jin H; Xu X
J Neuroinflammation; 2019 Dec; 16(1):278. PubMed ID: 31883532
[TBL] [Abstract][Full Text] [Related]
33. [High endothelial venules. Kinetics of the expression in IRBP-induced experimental autoimmune uveitis].
Stiemer R; Duijvestijn A; Wiggert B; Whitcup S; Zierhut M
Ophthalmologe; 1999 Jan; 96(1):40-4. PubMed ID: 10067334
[TBL] [Abstract][Full Text] [Related]
34. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein.
Hara Y; Caspi RR; Wiggert B; Chan CC; Wilbanks GA; Streilein JW
J Immunol; 1992 Mar; 148(6):1685-92. PubMed ID: 1531843
[TBL] [Abstract][Full Text] [Related]
35. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
[TBL] [Abstract][Full Text] [Related]
36. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
37. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
38. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
39. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance.
Bagenstose LM; Agarwal RK; Silver PB; Harlan DM; Hoffmann SC; Kampen RL; Chan CC; Caspi RR
J Immunol; 2005 Jul; 175(1):124-30. PubMed ID: 15972638
[TBL] [Abstract][Full Text] [Related]
40. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.
Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K
Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
